Loading…
Loading…
The IWP ETF is designed to mirror the investment performance of a specific benchmark. This benchmark is made up of medium-sized American companies that demonstrate strong potential for growth.
Is IWP's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Krilogy Financial LLC lifted its stake in shares of iShares Russell Mid-Cap Growth ETF (NYSEARCA:IWP) by 2.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 321,821 shares of the company's stock after purchasing an additional 8,280 shares during
Vertrix Wealth Management LLC acquired a new position in iShares Russell Mid-Cap Growth ETF (NYSEARCA:IWP) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 8,909 shares of the company's stock, valued at approximately $1,227,000. Other institutional investors
The iShares Russell Mid-Cap Growth ETF (IWP) was launched on July 17, 2001, and is a passively managed exchange traded fund designed to offer broad exposure to the Mid Cap Growth segment of the US equity market.
Park National Corp OH lessened its position in shares of iShares Russell Mid-Cap Growth ETF (NYSEARCA:IWP) by 51.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,418 shares of the company's stock after selling 3,597 shares
iShares Russell Mid-Cap Growth ETF is structurally constrained due to its mid-cap growth constraint, leading to persistent underperformance. IWP consistently lags both its own benchmark and broader growth ETFs like IWF, with a 2025 NAV return of 8.46% versus 8.66% for the benchmark. The fund's sector composition fails to capture the true drivers of market growth, resulting in a high P/E (37x) and P/B (12x) without commensurate returns.